ABBOTT LABORATORIES Insider Trading for April 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ABBOTT LABORATORIES.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ABBOTT LABORATORIES for April 2019.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | LIDDY EDWARD M | Director | Option Exercise | A | 78.06 | 11,606 | 905,964 | 11,606 | |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | LIDDY EDWARD M | Director | Grant | A | 0.00 | 2,241 | 0 | 28,153 | 25.9 K to 28.2 K (+8.65 %) |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | Stratton John G | Director | Grant | A | 0.00 | 2,241 | 0 | 8,641 | 6.4 K to 8.6 K (+35.02 %) |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | Stratton John G | Director | Grant | A | 0.00 | 2,241 | 0 | 8,641 | 6.4 K to 8.6 K (+35.02 %) |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | OSBORN WILLIAM A | Director | Option Exercise | A | 78.06 | 11,990 | 935,939 | 11,990 | |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | OSBORN WILLIAM A | Director | Option Exercise | A | 78.06 | 11,990 | 935,939 | 11,990 | |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | OSBORN WILLIAM A | Director | Grant | A | 0.00 | 2,241 | 0 | 56,323 | 54.1 K to 56.3 K (+4.14 %) |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | OSBORN WILLIAM A | Director | Grant | A | 0.00 | 2,241 | 0 | 56,323 | 54.1 K to 56.3 K (+4.14 %) |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | SCOTT SAMUEL C III | Director | Option Exercise | A | 78.06 | 10,146 | 791,997 | 10,146 | |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | SCOTT SAMUEL C III | Director | Option Exercise | A | 78.06 | 10,146 | 791,997 | 10,146 | |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | SCOTT SAMUEL C III | Director | Grant | A | 0.00 | 2,241 | 0 | 40,053 | 37.8 K to 40.1 K (+5.93 %) |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | SCOTT SAMUEL C III | Director | Grant | A | 0.00 | 2,241 | 0 | 40,053 | 37.8 K to 40.1 K (+5.93 %) |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | Blount Sally E. | Director | Grant | A | 0.00 | 2,241 | 0 | 28,766 | 26.5 K to 28.8 K (+8.45 %) |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | Blount Sally E. | Director | Grant | A | 0.00 | 2,241 | 0 | 28,766 | 26.5 K to 28.8 K (+8.45 %) |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | AUSTIN ROXANNE S | Director | Option Exercise | A | 78.06 | 11,683 | 911,975 | 11,683 | |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | AUSTIN ROXANNE S | Director | Grant | A | 0.00 | 2,241 | 0 | 44,913 | 42.7 K to 44.9 K (+5.25 %) |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Grant | A | 0.00 | 2,241 | 0 | 30,406 | 28.2 K to 30.4 K (+7.96 %) |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Grant | A | 0.00 | 2,241 | 0 | 7,018,425 | 7 M to 7 M (+0.03 %) |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | Kumbier Michelle | Director | Grant | A | 0.00 | 2,241 | 0 | 3,258 | 1 K to 3.3 K (+220.35 %) |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Grant | A | 0.00 | 2,241 | 0 | 41,053 | 38.8 K to 41.1 K (+5.77 %) |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | McKinstry Nancy | Director | Option Exercise | A | 78.06 | 10,146 | 791,997 | 10,146 | |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | McKinstry Nancy | Director | Grant | A | 0.00 | 2,241 | 0 | 23,666 | 21.4 K to 23.7 K (+10.46 %) |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | NOVAKOVIC PHEBE N | Director | Option Exercise | A | 78.06 | 10,837 | 845,936 | 10,837 | |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | NOVAKOVIC PHEBE N | Director | Grant | A | 0.00 | 2,241 | 0 | 26,333 | 24.1 K to 26.3 K (+9.30 %) |
Apr 29 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Option Exercise | M | 38.40 | 80,860 | 3,105,024 | 0 | |
Apr 29 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Option Exercise | M | 59.94 | 36,716 | 2,200,757 | 73,430 | |
Apr 29 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Option Exercise | M | 44.40 | 46,016 | 2,043,110 | 46,016 | |
Apr 29 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Payment of Exercise | F | 78.11 | 57,962 | 4,527,412 | 57,604 | 115.6 K to 57.6 K (-50.15 %) |
Apr 29 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Buy | M | 38.40 | 80,860 | 3,105,024 | 115,566 | 34.7 K to 115.6 K (+232.99 %) |
Apr 29 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 70.02 | 12,332 | 863,487 | 34,706 | 47 K to 34.7 K (-26.22 %) |
Apr 29 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 70.00 | 70,400 | 4,928,000 | 47,038 | 117.4 K to 47 K (-59.95 %) |
Apr 29 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Buy | M | 59.94 | 36,716 | 2,200,757 | 117,438 | 80.7 K to 117.4 K (+45.48 %) |
Apr 29 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Buy | M | 44.40 | 46,016 | 2,043,110 | 80,722 | 34.7 K to 80.7 K (+132.59 %) |
Apr 24 2019 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 47.00 | 56,000 | 2,632,000 | 113,227 | |
Apr 24 2019 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 76.00 | 56,000 | 4,256,000 | 169,935 | 225.9 K to 169.9 K (-24.79 %) |
Apr 24 2019 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 47.00 | 56,000 | 2,632,000 | 225,935 | 169.9 K to 225.9 K (+32.95 %) |
Apr 24 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 73.12 | 918 | 67,124 | 2,227 | 3.1 K to 2.2 K (-29.19 %) |
Apr 24 2019 | ABT | ABBOTT LABORATORIE ... | WOODGRIFT RANDEL WILLIAM | Senior Vice Preside ... | Buy | P | 73.40 | 2,000 | 146,798 | 52,562 | 50.6 K to 52.6 K (+3.96 %) |
Apr 03 2019 | ABT | ABBOTT LABORATORIE ... | WOODGRIFT RANDEL WILLIAM | Senior Vice Preside ... | Option Exercise | A | 79.98 | 43,388 | 3,470,172 | 43,388 | |
Apr 03 2019 | ABT | ABBOTT LABORATORIE ... | WOODGRIFT RANDEL WILLIAM | Senior Vice Preside ... | Grant | A | 0.00 | 8,278 | 0 | 50,562 | 42.3 K to 50.6 K (+19.58 %) |
Apr 03 2019 | ABT | ABBOTT LABORATORIE ... | Scoggins Christopher J | Senior Vice Preside ... | Option Exercise | A | 79.98 | 43,388 | 3,470,172 | 43,388 | |
Apr 03 2019 | ABT | ABBOTT LABORATORIE ... | Scoggins Christopher J | Senior Vice Preside ... | Grant | A | 0.00 | 8,278 | 0 | 33,578 | 25.3 K to 33.6 K (+32.72 %) |
Apr 02 2019 | ABT | ABBOTT LABORATORIE ... | Stratton John G | Director | Option Exercise | A | 0.00 | 394 | 0 | 3,492 | |
Apr 02 2019 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Option Exercise | A | 0.00 | 98 | 0 | 7,400 | |
Apr 02 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Payment of Exercise | F | 79.94 | 385 | 30,777 | 3,145 | 3.5 K to 3.1 K (-10.91 %) |
Apr 02 2019 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Grant | A | 0.00 | 935 | 0 | 3,530 | 2.6 K to 3.5 K (+36.03 %) |
Apr 02 2019 | ABT | ABBOTT LABORATORIE ... | LANE ANDREW H | Executive Vice Pres ... | Payment of Exercise | F | 79.94 | 365 | 29,178 | 45,932 | 46.3 K to 45.9 K (-0.79 %) |
Apr 02 2019 | ABT | ABBOTT LABORATORIE ... | LANE ANDREW H | Executive Vice Pres ... | Grant | A | 0.00 | 1,659 | 0 | 46,297 | 44.6 K to 46.3 K (+3.72 %) |